Eli Lilly and Company is scheduled to participate in the Citi's 2025 Global Healthcare Conference on December 2, 2025. The company will be represented by Ilya Yuffa, an executive vice president and president of Lilly USA and Global Customer Capabilities, who will take part in a fireside chat. Such investor conferences are important platforms for corporate leaders to provide insights into business performance, growth strategies, and the outlook for key products and research pipelines. Investors and analysts will be monitoring the discussion for any updates on the company's commercial execution and recent developments. There was no immediate market reaction as the company's participation was announced in mid-November. Any stock movement would likely occur during or after the presentation itself, based on the content and tone of the executive's remarks.